Suppr超能文献

NADPH 氧化酶、活性氧物质与肾脏:亦敌亦友。

NADPH oxidases, reactive oxygen species, and the kidney: friend and foe.

机构信息

Kidney Research Centre, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada;

出版信息

J Am Soc Nephrol. 2013 Oct;24(10):1512-8. doi: 10.1681/ASN.2012111112. Epub 2013 Aug 22.

Abstract

Reactive oxygen species (ROS) play an important role in normal cellular physiology. They regulate different biologic processes such as cell defense, hormone synthesis and signaling, activation of G protein-coupled receptors, and ion channels and kinases/phosphatases. ROS are also important regulators of transcription factors and gene expression. On the other hand, in pathologic conditions, a surplus of ROS in tissue results in oxidative stress with various injurious consequences such as inflammation and fibrosis. NADPH oxidases are one of the many sources of ROS in biologic systems, and there are seven isoforms (Nox1-5, Duox1, Duox2). Nox4 is the predominant form in the kidney, although Nox2 is also expressed. Nox4 has been implicated in the basal production of ROS in the kidney and in pathologic conditions such as diabetic nephropathy and CKD; upregulation of Nox4 may be important in renal oxidative stress and kidney injury. Although there is growing evidence indicating the involvement of NADPH oxidase in renal pathology, there is a paucity of information on the role of NADPH oxidase in the regulation of normal renal function. Here we provide an update on the role of NADPH oxidases and ROS in renal physiology and pathology.

摘要

活性氧 (ROS) 在正常细胞生理学中发挥着重要作用。它们调节着不同的生物过程,如细胞防御、激素合成和信号传递、G 蛋白偶联受体和离子通道及激酶/磷酸酶的激活。ROS 也是转录因子和基因表达的重要调节剂。另一方面,在病理条件下,组织中 ROS 的过剩会导致氧化应激,产生各种有害后果,如炎症和纤维化。NADPH 氧化酶是生物系统中 ROS 的众多来源之一,有七种同工型(Nox1-5、Duox1、Duox2)。Nox4 是肾脏中的主要形式,尽管 Nox2 也有表达。Nox4 参与了肾脏中 ROS 的基础产生以及糖尿病肾病和 CKD 等病理条件下的产生;Nox4 的上调可能在肾脏氧化应激和肾脏损伤中很重要。尽管越来越多的证据表明 NADPH 氧化酶参与了肾脏病理学,但关于 NADPH 氧化酶在调节正常肾功能中的作用的信息却很少。本文就 NADPH 氧化酶和 ROS 在肾脏生理学和病理学中的作用提供了最新进展。

相似文献

1
NADPH oxidases, reactive oxygen species, and the kidney: friend and foe.
J Am Soc Nephrol. 2013 Oct;24(10):1512-8. doi: 10.1681/ASN.2012111112. Epub 2013 Aug 22.
2
3
NADPH-oxidase 4 protects against kidney fibrosis during chronic renal injury.
J Am Soc Nephrol. 2012 Dec;23(12):1967-76. doi: 10.1681/ASN.2012040373. Epub 2012 Oct 25.
4
Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy.
Am J Physiol Renal Physiol. 2010 Dec;299(6):F1348-58. doi: 10.1152/ajprenal.00028.2010. Epub 2010 Jul 14.
5
NADPH oxidases in vascular pathology.
Antioxid Redox Signal. 2014 Jun 10;20(17):2794-814. doi: 10.1089/ars.2013.5607. Epub 2013 Nov 1.
6
The Nox family of NADPH oxidases: friend or foe of the vascular system?
Curr Hypertens Rep. 2012 Feb;14(1):70-8. doi: 10.1007/s11906-011-0238-3.
7
Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.
J Am Soc Nephrol. 2014 Jun;25(6):1237-54. doi: 10.1681/ASN.2013070810. Epub 2014 Feb 7.
8
APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury.
Lab Invest. 2017 Apr;97(4):419-431. doi: 10.1038/labinvest.2017.2. Epub 2017 Feb 6.
9
Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes.
Am J Physiol Renal Physiol. 2015 Jun 1;308(11):F1276-87. doi: 10.1152/ajprenal.00396.2014. Epub 2015 Feb 4.

引用本文的文献

2
Impaired Renal Function Due to Reductive Stress Is Associated with Excessive Consumption of .
Antioxidants (Basel). 2025 Aug 11;14(8):984. doi: 10.3390/antiox14080984.
3
Mangiferin Against Respiratory Diseases: Pharmacological Targets and Prospects.
Pharmacol Res Perspect. 2025 Aug;13(4):e70163. doi: 10.1002/prp2.70163.
4
Antioxidant, Antiinflammatory and Antiapoptotic Effects of Lycopene in Rats With Vancomycin-Induced Nephrotoxicity.
Basic Clin Pharmacol Toxicol. 2025 Aug;137(2):e70084. doi: 10.1111/bcpt.70084.
7
Microvesicles carrying EV71 virions cross BBB through endocytic pathway to induce brain injury.
Cell Commun Signal. 2025 Apr 14;23(1):183. doi: 10.1186/s12964-025-02195-y.

本文引用的文献

1
Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes.
Clin Sci (Lond). 2013 Feb;124(3):191-202. doi: 10.1042/CS20120330.
2
Role of renal DJ-1 in the pathogenesis of hypertension associated with increased reactive oxygen species production.
Hypertension. 2012 Feb;59(2):446-52. doi: 10.1161/HYPERTENSIONAHA.111.185744. Epub 2012 Jan 3.
3
Angiotensin II stimulates epithelial sodium channels in the cortical collecting duct of the rat kidney.
Am J Physiol Renal Physiol. 2012 Mar 15;302(6):F679-87. doi: 10.1152/ajprenal.00368.2011. Epub 2011 Dec 14.
4
Angiotensin II increases activity of the epithelial Na+ channel (ENaC) in distal nephron additively to aldosterone.
J Biol Chem. 2012 Jan 2;287(1):660-671. doi: 10.1074/jbc.M111.298919. Epub 2011 Nov 15.
5
Defective nitric oxide production impairs angiotensin II-induced Na-K-ATPase regulation in spontaneously hypertensive rats.
Am J Physiol Renal Physiol. 2012 Jan 1;302(1):F47-51. doi: 10.1152/ajprenal.00270.2011. Epub 2011 Sep 7.
6
Abundance of TRPC6 protein in glomerular mesangial cells is decreased by ROS and PKC in diabetes.
Am J Physiol Cell Physiol. 2011 Aug;301(2):C304-15. doi: 10.1152/ajpcell.00014.2011. Epub 2011 Apr 27.
7
NOX isoforms and reactive oxygen species in vascular health.
Mol Interv. 2011 Feb;11(1):27-35. doi: 10.1124/mi.11.1.5.
8
Inhibition of renal gluconeogenesis contributes to hypoglycaemic action of NADPH oxidase inhibitor, apocynin.
Chem Biol Interact. 2011 Jan 15;189(1-2):119-26. doi: 10.1016/j.cbi.2010.09.033. Epub 2010 Oct 8.
10
Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase.
Kidney Int. 2010 Nov;78(9):905-19. doi: 10.1038/ki.2010.265. Epub 2010 Aug 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验